Bactiguard underwent a major transformation in 2023. The company sharpened its strategy and is now focused on licensing the infection preventing coating technology to leading global MedTech companies. The license partnerships give Bactiguard global reach and the ability to scale the business in a cost-effective way while at the same time contribute to a healthier world by preventing infections.

“Our strategy is to support leading global MedTech companies in launching medical devices with our unique infection prevention coating technology – their products become premium and enables them to outperform competitors. We also create opportunities for the license partner to increase their market shares”, Thomas von Koch comments in his CEO statement.

Read more in Bactiguard Holding AB’s Annual and Sustainability Report 2023 here

Bactiguard Holding AB (publ) is obliged to make this information public under the Securities Markets Act. The information was submitted for publication at 08.00 CET on 11 April 2024.

For more information, please contact:
Patrick Bach, CFO +46 761 295 911
Nina Nornholm, Head of Communication & Investor Relations +46 708 550 356